𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast

✍ Scribed by Harper-Wynne, C; English, J; Meyer, L; Bower, M; Archer, C; Sinnett, H D; Lowdell, C; Coombes, R C

Book ID
110002658
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
74 KB
Volume
81
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized trial comparing cyclophospham
Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma
✍ Giorgio Cocconi; Beatrice Di Blasio; Corrado Boni; Giancarlo Bisagni; Guido Ceci πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 84 KB

## Abstract ## BACKGROUND According to the overview of Early Breast Cancer Trialists' Collaborative Group, anthracycline containing regimens are superior to cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) as adjuvant chemotherapy for breast carcinoma, but no comparative information is ava

Mitoxantrone, 5-fluorouracil, and high d
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial
✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding